Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2

Experimental Cell Research

Volumn 241, Issue 1, 1998, Pages 161-170

  Roeckl, Wolfgang ^a   Hecht, Dalit ^b   Sztajer, Helena ^a   Waltenberger, Johannes ^c   Yayon, Avner ^b   Weich, Herbert A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Angiogenesis; Endothelial cells; flt 1; Heparin; KDR; Soluble receptors; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

UNIDENTIFIED BACULOVIRUS;

EID: 0031867648     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4039     Document Type: Article

References (47)

1. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
2. Senger, D. R., van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K-T., Yeo, T-K., Berse, B., Jackman, R., Dvorak, A., and Dvorak, H. (1993). Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12, 303-324.
3. 165 and PDGF-BB. Anat. Embryol. 186, 251-257.
4. Connolly, D. T. (1991). Vascular permeability factor: A unique regulator of blood vessel function. J. Cell. Biochem. 47, 219-223.
5. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. (1991). The human gene for vascular endothelial growth factor. J. Biol. Chem. 266, 11947-11954.
6. Houck, K. A., Leung, D., Rowland, A. M., Winer, J., and Ferara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037.
7. Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., and Erikksson, U. (1996). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF) B and characterization of a second splice isoform. J. Biol. Chem. 271, 19310-19317.
8. Joukov, V., Pajusola, K., Kaipainen, H., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Lalkkinen, N., and Alitalo, K. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298.
9. Yamada, Y., Nezu, J., Shimane, M., and Hirata, Y. (1997). Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42, 483-488.
10. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Böhlen, P. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586.
11. Millauer, B., Wizigmann-Voss, S., Schnuerch, H., Martinez, R., Moeller, N. P., Risau, W., and Ullrich, A. (1993). High affinity binding and developmental expression suggest FLK-1 as a major regulator of angiogenesis and vasculogenesis. Cell 72, 835-846.
12. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.
13. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms-family. Oncogene 5, 519-524.
14. Kendall, R. L., Wang, G., DiSalvo, J., and Thomas, K. A. (1994). Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem. Biophys. Res. Commun. 201, 326-330.
15. Barleon, B., Hauser, S., Schoellmann, C., Weindel, K., Marmé, D., Yayon, A., and Weich, H. A. (1994). Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J. Cell. Biochem. 54, 56-66.
16. Thomas, K. A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271, 603-606.
17. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. (1994). Different signal transduction properties of KDR and FLT-1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
18. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995). Role of FLT-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 376, 66-70.
19. Shalaby, F., Rossant, J., Yamaguch, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., and Schuh, A. C. (1995). Failure of blood-island formation and vasulogenesis and Flk-1-deficient mice. Nature 376, 62-66.
20. Kendall, R. L., and Thomas, K. A. (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90, 10705-10709.
21. Kendall, R. L., Wang, G., and Thomas, K. A. (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, an its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324-328.
22. Gitay-Goren, H., Soker, H., Vlodavsky, I., and Neufeld, G. (1991). The binding of vascular endothelial growth factor to its receptor is dependent on cell surface associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098.
23. Gitay-Goren, H., Halaban, R., and Neufeld, G. (1993). Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun. 190, 702-709.
24. Terman, B. I., Khandre, L., Dougher-Vermazan, M., Maglione, D., Lassan, N. L., Gospodarowicz, D., Persico, G., Boehlen, P., and Eisinger, M. (1994). VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11, 187-195.
25. 165 with soluble and cell associated flk-1 receptors. J. Biol. Chem. 269, 12456-12461.
26. Fiebich, B. L., Jäger, B., Schöllmann, C., Weindel, K., Wilting, J., Kochs, G., Marmé, D., Hug, H., and Weich, H. A. (1993). Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur. J. Biochem. 211, 19-26.
27. Summers, M. D., and Smith, G. E. (1987). "A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures," Texas Agricultural Experimental Station, College Station, TX.
28. Corps, N., and Brown, D. (1988). Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin. Biochem. J. 252, 119-125.
29. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
30. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimota, T. (1990). Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157.
31. Soker, S., Svahn, C. M., and Neufeld, G. (1993). Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem. 268, 7685-7691.
32. Park, J. E. C., and Ferrara, N. (1994). Placenta growth factor. J. Biol. Chem. 269, 25646-25654.
33. Herren, B., Rooney, B., Weyer, K. A., Iber, N., Schmid, G., and Pech, M. (1993). Dimerization of extracellular domains of platelet-derived growth factor receptors. J. Biol. Chem. 268, 15088-15095.
34. 121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J. Biol. Chem. 271, 5519-5523.
35. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 270, 11322-11326.
36. Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., and Shibuya, M. (1996). Flt-1 but not KDR/FLK-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 7, 213-221.
37. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamagichi, S., and Shibuya, M. (1994). A unique signal transduction pathway for the FLT tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene 10, 135-147.
38. Siemeister, G., Schnurr, B., Mohrs, K., Schaechtele, C., Marmé, D., and Martiny-Baron, G. (1996). Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem. Biophys. Res. Commun. 222, 249-255.
39. Davis-Smyth, T., Chen, H., Park, J., Presta, L. G., and Ferrara, N. (1996). The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor FLT-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15, 4919-4927.
40. Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marmé, D., and Martiny-Baron, G. (1997). Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem. 272, 10382-10388.
41. Barleon, B., Sozzani, S., Thou, D., Weich, H. A., Mantovani, A., and Marmé, D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
42. Clauss, M., Weich, H. A., Breier, G., Knies, U., Röckl, W., Waltenberger, J., and Risau, W. (1996). The vascular endothelial growth factor receptor flt-1 mediates biological activities. J. Biol. Chem. 271, 17629-17634.
43. Plate, K., Breier, G., Weich, H. A., and Risau, W. (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848.
44. Weindel, K., Moringlane, J. R., Marmé, D., and Weich, H. A. (1994). Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35, 439-449.
45. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. (1993). Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53, 5822-5827.
46. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 363, 841-844.
47. Millauer, B., Shawvner, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.